reference

REFERENCE [1].“WHO Expert committee on specification for pharmaceutical preparation”, September 2, 2008. [2].“Good manufacturing practice guide for Active pharmaceutical ingredients”,August 23, 2008. [3]. A.A Olaniyi, “Drug Quality control Assurance and Pharmaceutical analysis”, 7, 19-27, 2000. [4].C.Burgess, “UV-Visible Spectrophotometry of Water and Waste water.Techniques and Instrumentation in Analytical Chemistry”, 27, 2007. [5].M.J.K.Thomas, Analytical Chemistry by Open Learning – Ultraviolet and VisibleSpectroscopy. Second Edition. University of Greenwich UK, John Wiley and Sons, Ltd., England, 1996. [6].D.G.Sporea ,R.A Sporea, Setup for the in situ monitoring of the irradiation-induced effects in optical fibers in the ultraviolet-visible optical range. Review of Scientific Instruments 76: 113110, 2005. [7].M.D.Pattergill, D.E.Sands, J. Chem. Educ, 58, 244,1979. [8].Pattergill. M.D, and Sands. D.E., Jour. Chem.Educ, 58, 244,1979. [9].A. B. Blank, Z. Anal. Chem, 17, 1040,1962. [10]I. S. Mustafin, Zavod. Lab,28, 664,1962.

~ 192 ~

[11]I. E. Banney, Talanta, 14, 1363,196. [12]S. B. Savvin, CRC Crit. Rev. Anal Chem, 8, 55,1979. [13]A. H. Ayres & B. D. Narang, Anal. Chem. Acta. 24, 241,1961. [14]E. B. Sandell, Colourimetric Determination of Traces of Metals, 3rd Edn,Inter Science, New York, 83,1959. [15]J. M. Green, Anal. Chem. News & Features, 305A,1996. [16]B. Renger, H. Jehle, M. Fischer & W. Funk, J. Planar Chrom, 269,1995. [17.]J. Vessman, J. Pharm. & Biomed. Analysis,14, 867,1996. [18]D. Marr, P. Horvath, B. J. Clark & A.F. Fell, Anal. Proceed, 23, 254,1986. [19]Guide for use of terms in reporting -data, “Anal. Chem”., 54, 157,1982. [20]D. A. Skoog, D. M. West & F. J. Holler, Fundamentals of Analytical Chemistry, 7th Edn., Saunders College Publishing, Philadelphia, 1996. [21]A.I.Vogel, Text Book

of Quantitative Chemical Analysis, 5th

Edn.,139,1989. [22]R. A. Storer, Annual Book of ASTM Standard (66 volumes in 16 sections),American Society for Testing and Materials, Philadelphia.1987. [23] B. J. Westenberger, C. D. Ellison, A. S. Fussner, S. Jenney, R. E. Kolinski, T. G. Lipe, R. C. Lyon, T. W. Moore, L. K. Revelle, and A. P. Smith, , International Journal of Pharmaceutics, 306, 56-70, 2005.

~ 193 ~

[24] R. A. Seburg, J. M. Ballard, T. L. Hwang, and C. M. Sullivan, Journal of Pharmaceutical and Biomedical Analysis, 42, 411-422, 2006. [25] R. Nageswara Rao, S. Meena, and A. Raghuram Rao, Journal of Pharmaceutical and Biomedical Analysis, 39, 349-363, 2005. [26] D. R. Bobbitt and S. W. Linder, Trends in Analytical Chemistry, 20,111-123, 2001. [27] L. Ma, H. Luo, J. Dai, and P. W. Carr, , Journal of Chromatography A, 1114, 21-28, 2006. [28] R. N. Goyal and A. Dhawan, Bioelectrochemistry, 69, 223-333, 2006. [29] C. H. Lin, H. L. Wu, and Y. L. Huang, Journal of Chromatography B, 829, 149-152, 2005. [30] L. Katata, V. Nagaraju, and A. M. Crouch, , Analytica Chimica Acta, 579, 177-184, 2006. [31] T. Guaratini, M. D. Gianeti, and P. M. B. G. Campos, International Journal of Pharmaceutics, 327, 12-16, 2006. [32] A. S. Rathore, S. E. Sobacke, T. J. Kocot, D. R. Morgan, R. L. Dufield, and N. M.Mozier, Journal of Pharmaceutical and Biomedical Analysis, 32, 1199-1211, 2003. [33] G. Jin, A. Aulabaugh, J. Pocas, H. Liu, R. Kriz, and D. Sampath, Analytical Biochemistry, 358, 59-69, 2006. [34] J. Chakel, A. Apffel, K. Hahnenberger, and G. Choudhary, European Journal of Pharmaceutical Sciences, 6, 19, 1998. ~ 194 ~

[35] E. Bossu, A. Montinaro, R. Lecce, A. Farina, E. Suppa, G. Draisci, and G. Gostoli,, Journal of Pharmaceutical and Biomedical Analysis, 42, 367371, 2006. [36] J. H. Contois, C. Hartigan, L. V. Rao, M. L. Snyder, and M. J. Thompson, Analytical validation of an HPLC assay for urinary albumin, Clinica Chimica Acta,367,150-155, 2006. [37] T. Arndt, U. Meier, M. Nauck, and A. M. Gressner, , Clinica Chimica Acta, 372, 184-187, 2006. [38] F. Gritti and G. Guiochon, Journal of Chromatography A, 1099, 1-42, 2005. [39] B. L. Karger, J. R. Gant, A. Martkopf, and P. H. Weiner, Journal of Chromatography A, 128, 65-78, 1976. [40] C. Horváth, W. Melander, and I. Molnar, Journal of Chromatography A,129-156, 1976. [41] D. M. Martire and R. E. Boehm, The Journal of Physical Chemistry, 87, 1045-1062, 1983. [42] K. A. Dill, The Journal of Physical Chemistry, 91, 1980-1988,1987. [43] L. C. Tan and P. W. Carr, Journal of Chromatography A, 799, 1-19, 1998. [44] K. B. Sentell and J. G. Dorsey,

Journal of Chromatography A,

461,193-207, 1989. [45] J. G. Dorsey and K. A. Dill, Chemistry Reviews, 89, 331-346, 1989. ~ 195 ~

[46] F. Riedo and E. Kovats, Journal of Chromatography, 239, 1-28, Apr.1982. [47] J. H. Knox and A. Pryde, Journal of Chromatography A,112, 71-188, 1975. [48] M. Yang, S. Fazio, D. Munch, and P. Drumm, Journal of Chromatography A, 1097,124-129, 2005. [49] Y. G. Guillaume and E. Peyrin, Talanta, 51,579-586, 2000. [50] D. V. McCalley, Journal of Chromatography A,902, 311-321, 2000. [51] J. K. Törnblom, T. F. W. Bureyko, and C. D. MacKinnon, Journal of Chromatography A, 1095,68-73, 2005. [52] J.W. Dolan, J.R. Gant, L.R. Snyder, J. Chromatogr.165 (1979) 31–58. [53] P.J. Schoenmakers, H.A.H. Billiet, R. Thijssen, L.de Galan, J. Chromatogr. 149 (1978) 519–537. [54] US Food and Drug Administration, Center for Drug Evaluation and Research, Guidance for Industry: Analytical Procedures and Methods Validation. Chemistry, Manufacturing, and Controls Documentation DRAFT GUIDANCE,Rockville,MD,2000. [55] US Food and Drug Administration, Center for Drug Evaluation and Research, Reviewer Guidance, Validation of Chromatographic Methods, Rockville, MD, 1994. http://www.fda.gov/CDER/GUIDANCE/cmc3.pdf. Retrieved: 05/04/2005.

~ 196 ~

[56] International Conference on Harmonization (ICH) of Technical Requirements for the registration of Pharmaceuticals for Human Use, Guideline for Industry Q2A.Text on Validation of Analytical Procedures, Geneva:1995.http://www.fda.gov/cder/Guidance/ichq2a.pdf.Retreived: 05/04/2005. [57] International Conference on Harmonization (ICH) of Technical Requirements for the registration of Pharmaceuticals for Human Use, Guidance

for

Industry

Q2BValidation

of

Analytical

Procedures:

Methodology,Geneva: 1996. [58] J. M. Green, A practical guide to analytical method validation, Analytical Chemistry, vol. 68, no. News and Features, 305A-309A, 1996. [59]EURACHEM,

The

Fitness

for

Purpose

of

Analytical

Methods-A

Laboratory Guide to Method Validation and Related Topics, 1998. [60]M. Thompson, S.L.R. Ellison, R. Wood,Harmonized guidelines for singlelaboratory validation of methods of analysis (IUPAC technical report), Pure Appl. Chem. 74, 835–855,2002. [61]Martindale, The complete drug reference, 34th Edition, 471,2001. [62]MR Goldberg , Y Lee, S ErmLich, Journal of clinical pharmacology, 40, 74-83,2000. [63]J Chen, X Jiang, W Jiang, N Mei, X Gao, Q Zhang, Journal of Chromatography B, Volume 805, Issue 1,169-173,2004. [64] T.Joseph Sunder Raj, Ch. Bharathi, M.Saravana Kumar, Joseph Prabahar, P. Naveen, Identification, isolation and characterization of process-related, in the biomedical and life sciences, 844(2):268-77,2006. ~ 197 ~

[65] JF Guo, AJ Zhang, L Zhao, XH Sun, YM YZhao, HZ Gao, ZY Liu, SY Qiao, Chromatography,20(1):61-6,2006. [66]Chen Y, Miao H, Lin M, Fan G, Hong Z, Wu H, Wu, Y, Journal of chromatography. B,844(2):268-77,2006. [67] B. Mallikarjuna Rao, Sivaiah Sangaraju, M.K.Srinivasu, P. Madhavan, M. Lalitha Devi, P. Rajendra Kumar, K.B. Chandrasekhar, Ch.Arpitha,T. Satya Balaji, Journal of Pharmaceutical and Biomedical Analysis, 41(4),1146-1151,2006. [68] I. Gopichand, A. Mittal, R. Kumar Thaper, S.Sivakumar, B. M.Rao, and M.K.Srinivasu,www.aapsj.org/abstracts/ /AAPS2003-001145.PDF. [69]Mira

Zecevic,

Biljana

Jocic,

Ljiljana

Zivanovic,

Ana

Protic,

Chromatographia,68 , 911-918,2008. [70] KamLesh P. Vyas, Rita A. Halpin, Leslie A. Geer, Joan D. Ellis, Lida Liu, Haiyung Cheng, Cynthia Chavez-Eng, Bogdan K. Matuszewski, Sandor L. Varga, Alexander R. Guiblin, J. D. Rogers, Drug Metabolism and Disposition, 28(1),89-95,2000. [71]J Bou, T Domenech, J Puig, A Heredia, J Gras, D Fernandez-Forner, J Beleta,J.M Palacios, Eur J Pharmacol, 410: 33-41,2000. [72] H Emil, H Joseph, D Hashmonai, J Emer Med, 3: 245-249,2003. [73] A Sharma, WJ Jusko, IE Fulmor, J Clin Pharmacol,39: 685-694,1999. [74] ICH Harmonized Tripartite Guidelines, Validation of analytical procedure methodology, 6th November, 1996.

~ 198 ~

[75] ICH Harmonized Tripartite Guidelines, Text on Validation of analytical procedure step-4 Q2A, October, 1994.

[76] Acharya Sasmita Kumari, Sahoo Subhasish, Dash Kiran Kaushik, M.M. Annapurna, International Journal of Chem Tech Research, 2(1), 653659,2010. [77] Sachin S Jagtap , C L Gopu , Kakasabeb R Mahadik, Mahadev V Mahadik,

Research Journal of Pharmaceutical, Biological and

Chemical Sciences, 1(2). 385-395, 2010.

[78]http://www.merckfrosst.ca/mfcl/en/corporate/research/accomplish ments/singulair.htm. [79]Schering-Plough Pharmaceuticals

press Receives

release Not-Approvable

Schering-Plough/MERCK Letter

from

FDA

for

Loratadine/Montelukast. [80]Smita Patil, Y. V. Pore, B. S. Kuchekar, Aruna Mane, V. G. Khire,Indian Journalof Pharmaceutical Sciences, 71(1), 58- 61,2009. [81]H. Ochiai, N. Uchiyama, T. Takano, K. Hara, T. Kamei, J Chromatogr B Biomed Sci Appl, 713 (2), 409-14, 1998. [82] I. Alsarra, N. Y. Khalil, M. Sultan, R. Al-Ashban, F. Belal, Pharmazie, 60(11),3-826,2005. [83] T. Radhakrishna, A. Narasaraju, M. Ramakrishna, A. Satyanarayana, Journal of Pharmaceutical and Biomedical Analysis,31(2), 359-368 (2003).

~ 199 ~

[84] Varun Pawar, N.Lalitha, S.B. Puranik, P.N. Sanjay Pai, G.K.Rao, KONGPOSH publications; 2008. [85] M. Saeed Arayne , Najma Sultana , Fida Hussain , Journal of Analytical Chemistry, 64(7) , 690-695, 2009. [86] K. Vanitha Prakash, J. Venkateswara Rao,N. Appala Raju, Oriental Journal of Chemistry, 23 (3), 2007. [87] Y. Shakalisava, F. Regan, J. Sep. Sci, 31(6-7), 1137-43,2008. [88] R.D. Amin, H. Cheng., J.D. Rogers, Pharm. Biomed. Anal., 13, 155– 158,1995. [89] Yao Huang, Li Ding, Yuan-Yuan Liu, He-Ying Liu, Ai-Dong Wen, Lin Yang, Journal of Chinese Pharmaceutical Sciences, 18 (3), 261-266,2006. [90] S.Tzvetanov, M. Vatsova, A. Drenska, J. Gorantcheva, and N. Tyutyul Kova, J.Chromatogr. B Biomed. Sci. Appl., 732, 251,1999. [91] X. Chen, D. zhong, D. Liu, Y. Wang, H. Han, and J. Gu, Rapid Commun. Mass Spectrom. 17, 2459,2003. [92] F. Q. Alali, B. M. Tashtoush, and N. M. Najib, J. Pham. Biomed. Anal.34, 87,2004. [93] D. Wang, and R. C. Chao, J. Pharm. Sci., 14 ,122,1999. [94] M. M. Khater, Y. M. Issa, and S. H. Mohammed, Bioelectrochemistry, 77, 53,2009. [95]W. Ciesielski, R. Zakrzewki, and U. Zlobinska, Pharmize, 60, 237,2005. ~ 200 ~

[96] C. S. P. Sastry, and P. Y. Naidu, Microchem. Acta, 127, 219,1997. [97] Luga, C. Bojita, M. Hudrea, F. and Miron, M,. Farmacia (Bucharest), 45: 43-51 1997. [98] Salama.F., El-Abasawy.N., Abdel Razeq.S.A.,Ismail,M.M.F., Fouad.M. M., J. Pharm.Biomed. Anal. 33: 411-421,2003. [99] Wahbi, A-A. M., Abdel-Razak, O., Gazy, A. A.,Mahgoub, H. , Moneeb.M. S. J. Pharm.Biomed. Anal. 30: 1133-1142, 2002. [100]Karljikovic-Rajic.K,Novovic.D,Marinkovic.V,Agbaba.,J.Pharm.Biomed. Anal. 32: 1019-1027,2003. [101]Castro.D.,Moreno.M.A.,Torrado.S.,Lastres.J.L,J.Pharm.Biomed.Anal.21: 291-298,1999. [102] Ruiz,M.A, Reyes.I., Parera.A. , Gallardo.V., J.Therm.Anal.Calorim. 51: 29-35,1998. [103] Ekpe.A, Jacobsen. T, Ind. Pharm. 25: 1057-1065, 1999.

[104] Nevado. J.J.B.G.C, Peñlvo.R.M, Dorado.R,.Anal. Chim. Acta,2004.

~ 201 ~